Exagen Inc. ( XGN) - Key Metrics
XGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.83 | -$0.13 | $0.17 | $0.14 |
| 2026Q1 | $0.73 | -$0.17 | -$0.44 | -$0.45 |
| 2025Q4 | $0.77 | -$0.22 | -$0.14 | -$0.14 |
| 2025Q3 | $0.75 | -$0.31 | $0.13 | $0.12 |
| 2025Q2 | $0.82 | -$0.21 | -$0.14 | -$0.15 |
XGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.94 |
| 2026Q1 | 0% | -4.41 |
| 2025Q4 | 0% | -7.24 |
| 2025Q3 | 0% | -8.86 |
| 2025Q2 | 0% | -8.31 |
XGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.07% | 0% |
| 2026Q1 | -14.87% | 0% |
| 2025Q4 | -2.33% | 0% |
| 2025Q3 | 1.06% | 0% |
| 2025Q2 | -2.10% | 0% |
XGN
Price: $7.58
52 week price:
Earnings Per Share: -0.80 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 10300
Market Capitalization: 160.9 million